The putative tumor suppressor gene EphA7 is a novel BMI-1 target

8Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Bmi1 was originally identified as a gene that contributes to the development of mouse lymphoma by inhibiting MYC-induced apoptosis through repression of Ink4a and Arf. It codes for the Polycomb group protein BMI-1 and acts primarily as a transcriptional repressor via chromatin modifications. Although it binds to a large number of genomic regions, the direct BMI-1 target genes described so far do not explain the full spectrum of BMI-1-mediated effects. Here we identify the putative tumor suppressor gene EphA7 as a novel direct BMI-1 target in neural cells and lymphocytes. EphA7 silencing has been reported in several different human tumor types including lymphomas, and our data suggest BMI1 overexpression as a novel mechanism leading to EphA7 inactivation via H3K27 trimethylation and DNA methylation.

Cite

CITATION STYLE

APA

Prost, G., Braun, S., Hertwig, F., Winkler, M., Jagemann, L., Nolbrant, S., … Nuber, U. A. (2016). The putative tumor suppressor gene EphA7 is a novel BMI-1 target. Oncotarget, 7(36), 58203–58217. https://doi.org/10.18632/oncotarget.11279

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free